An Observational Study to Learn More About How Well a Treatment Works When Given After Treatment With Atezolizumab and Bevacizumab or Another Similar Combination of Drugs in Adults With Liver Cancer That Cannot be Treated With Surgery
Clinical trial NCT06117891 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06117891
- Sponsor
- Bayer
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2023-11-27
- Primary completion
- 2025-12-10
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.